Ideas to action: independent research for global prosperity
Search
Filters:
Experts
Facet Toggle
Topics
Facet Toggle
Content Type
Facet Toggle
Publication Type
Facet Toggle
Article Type
Facet Toggle
Time Frame
Facet Toggle
Blog Post
February 08, 2024
With several replenishment campaigns set for 2024-2025, a fundraising pileup is on the horizon. Close to a dozen major development funds—including the World Bank’s International Development Association (IDA), thematic funds like Gavi, and new entities like the Loss and Damage Fund—could aim to raise...
Blog Post
September 21, 2023
The likelihood of capital increase for the World Bank’s non-concessional lending arm, the IBRD, appears to be climbing. At least an odd European government appears to be doing some preparatory work for it. But any negotiations around a capital increase may be complex. Large shareholders and borrowe...
Blog Post
August 16, 2023
Despite verbal nods to global cooperation, equity, and solidarity, the COVID-19 pandemic laid bare a brutal realpolitik: all countries will put their citizens first and vaccinate their own populations, before offering charitable leftovers beyond their own borders. Sub-Saharan Africa, more than any o...
Blog Post
March 07, 2023
The EU and its member states are collectively the world’s largest aid donor, with an annual budget of over $70 billion in 2021. When it comes to global health, however, it has historically punched below its weight. In part, this is due to an internal coordination problem; health is a shared competen...
CGD NOTES
December 14, 2022
Almost a year after two oral antiviral treatments received emergency use authorization, demand is extremely low. In this note, we argue that governments and their donor partners should use data and evidence to consider the economic and clinical rationale for registering, financing, purchasing, and d...
Blog Post
December 14, 2022
Four new CGD pieces, released today, examine the current state of play on COVID-19 oral antivirals. Our analyses provide a deep-dive in key cross-cutting areas—demand, voluntary licensing deals for generic supply, and deployment—and offer policy actions for 2023 and beyond.
Nov
14
2022
VIRTUAL
8:30—12:00 PM Eastern Time (US & Canada)/ 1:30—5:00pm Greenwich Mean Time (GMT)
October 28, 2022
Climate change, conflict, food insecurity, and pandemics. These global challenges are growing in urgency, and complexity—and they are not confined by borders. While wealthy countries are aging and their growth rates are faltering, the traditional manufacturing-led path to rapid growth in poorer coun...
Blog Post
October 05, 2022
It is surely an urgent moment for multilateral support from the IMF and World Bank. And yet, the institutions’ financial statements suggest that support is declining. Figuring out why and what to do about it should be priority one at the upcoming World Bank-IMF annual meetings.
Blog Post
August 10, 2022
PEPFAR’s new strategy—to be released in final form later this year—focuses on how to accelerate progress toward epidemic control amidst continued impacts from COVID-19, while also strengthening core health system functions as well as partnership and coordination efforts; this is precisely what the c...